Revolution Medicines, Inc. Warrant
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Revolution Medicines, Inc. Warrant's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 73% to $11,580,000. Profit margin reached -3768%. Total operating expenses were $498,765,000.

Profit Margin

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Profit margin
2017 0 -31.12M
2020 42.98M -108.15M -251.63%
2023 11.58M -436.36M -3768.28%

RVMDW Income Statement (2017 – 2023)

2023 2020 2017
Revenue
Revenue
11.58M42.98M0
Cost of revenue
0132.25M1.18M
Gross profit
11.58M-89.26M-1.18M
Operating exp.
Research and development
423.14M132.25M26.58M
Selling and marketing
000
Total operating expenses
498.76M153.68M31.12M
Operating income
-487.18M-110.69M-31.12M
Other income (expenses), net
47.29M2.16M2K
Income before tax
-439.89M-108.53M-31.12M
Income tax expense
-3.52M-371K105K
Net income
-436.36M-108.15M-31.12M
Earnings per share
Basic EPS
-3.86-1.62-0.85
Diluted EPS
-3.86-1.62-0.85
Data sourceData source